|
Re: Presentations-FYI...
|
4
|
Resverlogix Corp.
|
Jan 09, 2018 11:37AM
|
|
Re: Presentations & Events
|
3
|
Resverlogix Corp.
|
Jan 05, 2024 04:26PM
|
|
Re: Presentation slides are up
|
6
|
Zenith Epigenetics
|
Jun 18, 2020 12:06PM
|
|
Re: Presentation May 12th
|
3
|
Resverlogix Corp.
|
May 09, 2021 04:17PM
|
|
Re: Presentation is up
|
4
|
Zenith Epigenetics
|
Jan 09, 2018 01:49PM
|
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 16, 2021 11:51PM
|
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
May 13, 2021 06:52PM
|
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
May 13, 2021 06:56PM
|
|
Re: Presentation
|
6
|
Resverlogix Corp.
|
Jun 20, 2017 03:16AM
|
|
Re: Presentation
|
2
|
Zenith Epigenetics
|
Nov 03, 2017 04:23PM
|
|
Re: Precedence in Gene Therapy Pricing
|
6
|
Resverlogix Corp.
|
Jan 03, 2018 12:40PM
|
|
Re: Precedence in Gene Therapy Pricing
|
4
|
Resverlogix Corp.
|
Jan 04, 2018 02:02AM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
2
|
Resverlogix Corp.
|
Jan 11, 2018 01:48AM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 14, 2022 05:12PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 15, 2022 12:21PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 18, 2022 09:06PM
|
|
Re: Potential Market Size
|
1
|
Resverlogix Corp.
|
Apr 18, 2019 05:12PM
|
|
Re: Potential market
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 03:21AM
|
|
Re: Posters out
|
2
|
Resverlogix Corp.
|
May 14, 2019 08:22PM
|
|
Re: Posted on other board by jkj from Google alert / Old or new news?
|
7
|
Resverlogix Corp.
|
Apr 18, 2021 04:52PM
|
